Genedrive (LON:GDR) had its price target lifted by Peel Hunt from GBX 150 ($2.07) to GBX 152 ($2.10) in a research report sent to investors on Tuesday. They currently have a buy rating on the stock.

Genedrive (LON GDR) opened at GBX 35 ($0.48) on Tuesday. The stock has a market capitalization of $5.58 and a P/E ratio of -100.00. Genedrive has a 1 year low of GBX 25 ($0.35) and a 1 year high of GBX 45.49 ($0.63).

ILLEGAL ACTIVITY WARNING: This article was first published by Daily Political and is the sole property of of Daily Political. If you are viewing this article on another site, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this article can be viewed at

Genedrive Company Profile

Genedrive Plc, formerly Epistem Holdings Plc, is a holding company engaged in molecular diagnostics business. The Company operates through segments, including Preclinical Research Services, Pharmacogenomics Services and Diagnostics. Its geographical segments include the United Kingdom, Europe, the United States of America and Asia.

Receive News & Ratings for Genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genedrive and related companies with's FREE daily email newsletter.